Dan Zabrowski Appointed Global Head, Roche Pharma Partnering
Roche has announced that Dan Zabrowski, Ph.D., currently Global Head Pharma Development Operations in Nutley, NJ, will assume the position of Global Head, Roche Pharma Partnering effective July 1, 2007. In his new assignment, Zabrowski will oversee Roche’s world-class network of strategic alliances with biotech companies and create new alliances in the future. He will report to William M. Burns, CEO, Pharmaceuticals Division, Roche. Zabrowski succeeds Peter Hug, who will become Head of the Roche Pharmaceuticals Western Europe Region.
According to William M. Burns, “Roche’s focus on building strong and lasting partnerships has become an industry standard, and Dan’s strong background in drug development and regulatory affairs will be particularly important as we continue to expand our network of more than 60 global partners.”
“Innovation is the foundation for everything that we do at Roche. I look forward to working with all of our partner companies as well as creating new exciting relationships to advance the development of new, effective treatments that can help patients worldwide,” said Zabrowski.
Currently, Zabrowski is responsible for both the U.S. Development organization in Nutley and the management of all global clinical trials for the Pharma Division. Prior to this, he served as head, Global Regulatory Affairs at Roche. He joined Roche in 1995 following the company’s acquisition of Syntex, Inc., where he held a variety of positions in Regulatory Affairs. Before Syntex, Zabrowski led Regulatory Affairs in North America for Fujisawa Pharmaceutical Company. He began his career as a researcher at G.D. Searle Pharmaceuticals.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.